Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
AU2013205129B2 - Plasma kallikrein binding proteins - Google Patents
[go: Go Back, main page]

AU2013205129B2 - Plasma kallikrein binding proteins - Google Patents

Plasma kallikrein binding proteins

Info

Publication number
AU2013205129B2
AU2013205129B2 AU2013205129A AU2013205129A AU2013205129B2 AU 2013205129 B2 AU2013205129 B2 AU 2013205129B2 AU 2013205129 A AU2013205129 A AU 2013205129A AU 2013205129 A AU2013205129 A AU 2013205129A AU 2013205129 B2 AU2013205129 B2 AU 2013205129B2
Authority
AU
Australia
Prior art keywords
binding proteins
plasma kallikrein
kallikrein binding
proteins
plasma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active, expires
Application number
AU2013205129A
Other versions
AU2013205129A1 (en
Inventor
Daniel J. Sexton
Malini VISWANATHAN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2011204349A external-priority patent/AU2011204349C1/en
Priority to AU2013205129A priority Critical patent/AU2013205129B2/en
Application filed by Takeda Pharmaceutical Co Ltd filed Critical Takeda Pharmaceutical Co Ltd
Publication of AU2013205129A1 publication Critical patent/AU2013205129A1/en
Application granted granted Critical
Publication of AU2013205129B2 publication Critical patent/AU2013205129B2/en
Priority to AU2016244213A priority patent/AU2016244213B2/en
Priority to AU2018253476A priority patent/AU2018253476C1/en
Priority to AU2019204295A priority patent/AU2019204295B2/en
Priority to AU2020204600A priority patent/AU2020204600B2/en
Assigned to TAKEDA PHARMACEUTICAL COMPANY LIMITED reassignment TAKEDA PHARMACEUTICAL COMPANY LIMITED Request for Assignment Assignors: DYAX CORP.
Priority to AU2023278128A priority patent/AU2023278128A1/en
Active legal-status Critical Current
Adjusted expiration legal-status Critical

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

PLASMA KALLIKREIN BINDING PROTEINS Plasma kallikrein binding proteins and methods of using such proteins are described.
AU2013205129A 2010-01-06 2013-04-13 Plasma kallikrein binding proteins Active 2034-01-30 AU2013205129B2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
AU2013205129A AU2013205129B2 (en) 2010-01-06 2013-04-13 Plasma kallikrein binding proteins
AU2016244213A AU2016244213B2 (en) 2010-01-06 2016-10-11 Plasma kallikrein binding proteins
AU2018253476A AU2018253476C1 (en) 2010-01-06 2018-10-23 Plasma kallikrein binding proteins
AU2019204295A AU2019204295B2 (en) 2010-01-06 2019-06-19 Plasma kallikrein binding proteins
AU2020204600A AU2020204600B2 (en) 2010-01-06 2020-07-09 Plasma kallikrein binding proteins
AU2023278128A AU2023278128A1 (en) 2010-01-06 2023-12-11 Plasma kallikrein binding proteins

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61/292,614 2010-01-06
AU2011204349A AU2011204349C1 (en) 2010-01-06 2011-01-06 Plasma kallikrein binding proteins
AU2013205129A AU2013205129B2 (en) 2010-01-06 2013-04-13 Plasma kallikrein binding proteins

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2011204349A Division AU2011204349C1 (en) 2010-01-06 2011-01-06 Plasma kallikrein binding proteins

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2016244213A Division AU2016244213B2 (en) 2010-01-06 2016-10-11 Plasma kallikrein binding proteins

Publications (2)

Publication Number Publication Date
AU2013205129A1 AU2013205129A1 (en) 2013-05-16
AU2013205129B2 true AU2013205129B2 (en) 2016-07-14

Family

ID=48538150

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2013205129A Active 2034-01-30 AU2013205129B2 (en) 2010-01-06 2013-04-13 Plasma kallikrein binding proteins
AU2023278128A Pending AU2023278128A1 (en) 2010-01-06 2023-12-11 Plasma kallikrein binding proteins

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2023278128A Pending AU2023278128A1 (en) 2010-01-06 2023-12-11 Plasma kallikrein binding proteins

Country Status (1)

Country Link
AU (2) AU2013205129B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12487299B2 (en) 2022-06-20 2025-12-02 Shanghai United Imaging Healthcare Co., Ltd. Magnetic resonance imaging devices and radiation therapy systems including the magnetic resonance imaging devices

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12487299B2 (en) 2022-06-20 2025-12-02 Shanghai United Imaging Healthcare Co., Ltd. Magnetic resonance imaging devices and radiation therapy systems including the magnetic resonance imaging devices

Also Published As

Publication number Publication date
AU2023278128A1 (en) 2024-01-04
AU2013205129A1 (en) 2013-05-16

Similar Documents

Publication Publication Date Title
CY1125705T1 (en) PLASMA KALLIKREIN BINDING PROTEINS
EP2539473B8 (en) Modified proteins and methods of making and using same
EP4302783A3 (en) Modified relaxin polypeptides and their uses
EP2566890A4 (en) Anti-pai-1 antibodies and methods of use thereof
PH12013501339A1 (en) Anti-pcsk9 antibodies and methods of use
MX340555B (en) Antibodies against il-18r1 and uses thereof.
PH12014501427A1 (en) Anti-php-tau antibodies and their uses
EP4223770A3 (en) Novel fusion molecules and uses thereof
UA118328C2 (en) Targeted gemomic alteration
MX336001B (en) Anti-axl antibodies and methods of use.
MX2013015311A (en) Pcsk9-binding polypeptides and methods of use.
MX2014002053A (en) Anti-mcsp antibodies.
AU2011323828A8 (en) Chromobacterium bioactive compositions and metabolites
WO2013078217A3 (en) Anti-microbial peptides and methods of use thereof
MX2012011829A (en) Anti-polyubiquitin antibodies and methods of use.
EP2547782B8 (en) Methods, kits and compositions for detection of mrsa
PH12013500500A1 (en) Fused heteroaryls and their uses
WO2013163297A8 (en) Modified glycoproteins
WO2012078816A9 (en) Proteins that efficiently generate singlet oxygen
MX350452B (en) Cooling and processing materials.
EP2601316A4 (en) Hide processing methods and compositions
AU2013205129B2 (en) Plasma kallikrein binding proteins
MX2013005699A (en) Stable preserved compositions if interferon-beta.
WO2012091777A3 (en) Complementary biasing circuits and related methods
HK1192759A (en) Plasma kallikrein binding proteins

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
NC Extension of term for standard patent requested (sect. 70)

Free format text: PRODUCT NAME: TAKHZYRO LANADELUMAB

Filing date: 20190130

NDA Extension of term for standard patent accepted (sect.70)

Free format text: PRODUCT NAME: TAKHZYRO LANADELUMAB

Filing date: 20190130

NDB Extension of term for standard patent granted (sect.76)

Free format text: PRODUCT NAME: TAKHZYRO LANADELUMAB

Filing date: 20190130

Extension date: 20340130

DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE NAME OF THE INVENTOR TO READ SEXTON, DANIEL J. AND VISWANATHAN, MALINI

DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE NAME OF THE INVENTOR TO READ SEXTON, DANIEL J. AND VISWANATHAN, MALINI

PC Assignment registered

Owner name: TAKEDA PHARMACEUTICAL COMPANY LIMITED

Free format text: FORMER OWNER(S): DYAX CORP.